TARS Total Non-Current Liabilities
Tarsus Pharmaceuticals Inc · Total Non-Current Liabilities
TARS Total Non-Current Liabilities
Latest reported$88.66Mperiod ending
TARS Quarterly Total Non-Current Liabilities ($63.50M → $88.66M)
Quarterly total non-current liabilities
High-resolution chart · PNG
TARS total non-current liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 88,657,000 | |
| 88,675,999 | |
| 83,037,000 | |
| 82,429,000 | |
| 72,129,000 | |
| 71,984,000 | |
| 71,845,000 | |
| 72,948,000 | |
| 73,027,000 | |
| 31,539,000 | |
| 31,567,000 | |
| 31,419,000 | |
| 26,433,000 | |
| 24,555,000 | |
| 19,534,000 | |
| 19,565,000 | |
| 19,605,000 | |
| 19,676,000 | |
| 699,000 | |
| 905,000 | |
| 524,000 | |
| 604,000 | |
| 605,000 | |
| 103,870,000 | |
| 797,000 | |
| 63,502,000 |